{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:42:04Z","timestamp":1777693324226,"version":"3.51.4"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.1001\/jamadermatol.2021.2120","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T15:02:00Z","timestamp":1624460520000},"page":"947","source":"Crossref","is-referenced-by-count":32,"title":["Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic"],"prefix":"10.1001","volume":"157","author":[{"given":"Patrick E.","family":"McCleskey","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bree","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"},{"name":"Department of Pediatrics, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amara","family":"Lieberman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Research, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzam","family":"Gorouhi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine C.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achyuth","family":"Sriram","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Thornton","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnd M.","family":"Herz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Permanente Medical Group, Northern California, Oakland"},{"name":"Department of Infectious Disease, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paradi","family":"Mirmirani","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa J.","family":"Herrinton","sequence":"additional","affiliation":[{"name":"Division of Research, The Permanente Medical Group, Northern California, Oakland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"7","key":"doi210026r1","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1111\/jdv.v34.7","article-title":"Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.","volume":"34","author":"Piccolo","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi210026r2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bjd.v183.1","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"issue":"8","key":"doi210026r3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/ced.v45.8","article-title":"Novel outbreak of acral lesions in times of COVID-19: a description of 74 cases from a tertiary university hospital in Spain.","volume":"45","author":"Saenz Aguirre","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"doi210026r4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France.","volume":"83","author":"de Masson","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi210026r5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/bjd.v183.5","article-title":"Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.","volume":"183","author":"Le Cleach","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi210026r6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjd.v183.4","article-title":"No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.","volume":"183","author":"Caselli","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi210026r7","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1111\/jdv.v35.1","article-title":"Chilblains and COVID-19: further evidence against a causal association.","volume":"35","author":"Baeck","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"doi210026r8","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/ijd.v59.12","article-title":"High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.","volume":"59","author":"G\u00f3mez-Fern\u00e1ndez","year":"2020","journal-title":"Int J Dermatol"},{"issue":"9","key":"doi210026r9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamadermatol.2020.2340","article-title":"Assessment of acute acral lesions in a case series of children and adolescents during the COVID-19 pandemic.","volume":"156","author":"Roca-Gin\u00e9s","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"11","key":"doi210026r10","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1111\/jdv.v34.11","article-title":"Major cluster of paediatric \u201ctrue\u201d primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.","volume":"34","author":"Neri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"doi210026r11","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.3390\/jcm9103261","article-title":"Skin manifestations in COVID-19: prevalence and relationship with disease severity.","volume":"9","author":"Giavedoni","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"doi210026r12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.mayocp.2013.09.020","article-title":"Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011.","volume":"89","author":"Cappel","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"doi210026r13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00005792-200105000-00004","article-title":"Clinical and histopathologic features and immunologic variables in patients with severe chilblains: a study of the relationship to lupus erythematosus.","volume":"80","author":"Viguier","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"doi210026r14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/ced.2012.37.issue-8","article-title":"Epidemiological patterns of perniosis, and its association with systemic disorder.","volume":"37","author":"Takci","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"doi210026r15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0046-8177(97)90038-1","article-title":"Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases.","volume":"28","author":"Crowson","year":"1997","journal-title":"Hum Pathol"},{"issue":"3","key":"doi210026r16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.mjafi.2013.01.011","article-title":"Pattern of chilblains in a high altitude region of Ladakh, India.","volume":"71","author":"Singh","year":"2015","journal-title":"Med J Armed Forces India"},{"issue":"3","key":"doi210026r18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/bjd.v183.3","article-title":"Absence of images of skin of colour in publications of COVID-19 skin manifestations.","volume":"183","author":"Lester","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi210026r19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjd.v183.4","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi210026r20","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/bjd.v183.6","article-title":"Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned.","volume":"183","author":"Baeck","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi210026r21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamadermatol.2020.4937","article-title":"Emerging evidence of the direct association between COVID-19 and chilblains.","volume":"157","author":"Freeman","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi210026r22","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/j.jaad.2020.06.052","article-title":"When interferon tiptoes through COVID-19: pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.","volume":"83","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi210026r23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamadermatol.2020.4324","article-title":"Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic.","volume":"157","author":"Hubiche","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi210026r24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1473-3099(20)30518-1","article-title":"Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.","volume":"21","author":"Hubiche","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"doi210026r25","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/jdv.v34.11","article-title":"A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.","volume":"34","author":"El Hachem","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi210026r17","unstructured":"Cowan? G, Bellisario? J. Remote work in the Bay Area: an initial evaluation of the data and implications for public policy. Bay Area Council. December 20, 2020. Accessed December 21, 2020. http:\/\/www.bayareaeconomy.org\/wp-content\/uploads\/2020\/12\/BACEI_RemoteWork_12.21.20.pdf"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2781362\/jamadermatology_mccleskey_2021_oi_210026_1628612394.36002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T15:21:41Z","timestamp":1629300101000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2781362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.2120","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}